Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Cyclacel Pharmaceuti

(NASDAQ: CYCC)
Add to Portfolio
+0.62 (+30.69%)
as of May 31, 2024


Date Form Description HTML Word PDF Excel
May 17, 2024 D Small Company Offering and Sale of Securities Without Registration  
May 14, 2024 10-Q Quarterly Report
May 14, 2024 8-K Current report filing
May 13, 2024 424B3 Prospectus filed pursuant to Rule 424(b)(3)  
May 08, 2024 ARS Annual Report to Security Holders  
May 08, 2024 DEFA14A Additional Proxy Soliciting Materials (definitive)  
May 08, 2024 DEF 14A Proxy Statement (definitive)  
May 06, 2024 S-1 Securities Registration Statement  
May 02, 2024 8-K Current report filing
Apr 29, 2024 10-K/A Amended Annual Report
Apr 29, 2024 RW Withdrawal of Registration Statement  
Apr 26, 2024 8-K Current report filing
Apr 25, 2024 S-1/A Securities Registration Statement  
Apr 19, 2024 S-1/A Securities Registration Statement  
Mar 28, 2024 8-K Current report filing
Mar 22, 2024 S-1 Securities Registration Statement  
Mar 21, 2024 10-K Annual Report
Mar 19, 2024 8-K Current report filing
Feb 14, 2024 424B3 Prospectus filed pursuant to Rule 424(b)(3)  
Feb 08, 2024 S-1/A Securities Registration Statement  
Jan 30, 2024 8-K Current report filing
Jan 19, 2024 S-1 Securities Registration Statement  
Jan 12, 2024 8-K Current report filing
Jan 10, 2024 SC 13G Statement of Ownership  
Jan 09, 2024 8-K Current report filing